Antibodies

Whitepaper: Simple Western™ produces publication-ready results

24 March 2021 | By Bio-Techne

Simple Western™ is an automated capillary immunoassay that produces publication-ready data to meet the highest standards of data integrity and rigor.

Catalogue: Nuclease-Free tubes, tips & buffers

22 March 2021 | By Thermo Fisher Scientfic

Working with RNA requires rigorous nuclease contamination controls in place. Stock up on Nuclease-Free tubes tips and buffers #Back2Lab

Team uses antibodies to tag disease-related proteins for destruction

19 March 2021 | By Victoria Rees (Drug Target Review)

Researchers have developed a technique utilising antibodies to tag disease-causing proteins, to treat the underlying causes of disease.

Antibodies from COVID-19 vaccines less effective against SARS-CoV-2 variants

15 March 2021 | By Victoria Rees (Drug Target Review)

Researchers have shown antibodies induced by the Pfizer and Moderna vaccines are less effective at neutralising certain SARS-CoV-2 variants.

Podcast: SARS-CoV-2 molecular testing

12 March 2021 | By Thermo Fisher Scientfic

New podcast on SARS-CoV-2 molecular testing: From human sample analysis to Wastewater Surveillance.

Catalogue: Ribosomal RNA from bacteria with RiboMinus

10 March 2021 | By Thermo Fisher Scientfic

RiboMinus Bacteria 2.0 Transcriptome Isolation Kits perform efficient transcriptome enrichment from total bacterial RNA. Improve your RNA extraction from bacteria today.

Study shows role IgM antibodies play in preventing thrombosis

10 March 2021 | By Victoria Rees (Drug Target Review)

A new study has revealed that immunoglobulin-M antibodies recognise microvesicles, which are critical for the progression of thrombosis.

Researchers identify antibodies with potent effects against malaria

8 March 2021 | By Victoria Rees (Drug Target Review)

Six antibodies specific to the circumsporozoite protein of the malaria parasite have shown promise as therapeutic interventions, a study has shown.

SARS-CoV-2 mAb cocktail effective against all known variants of virus

8 March 2021 | By Victoria Rees (Drug Target Review)

A monoclonal antibody (mAb) cocktail, that targets sites on the Spike protein other than the E484K residue, can neutralise SARS-CoV-2.

Nanoparticle COVID-19 vaccine shows promise in pre-clinical trials

3 March 2021 | By Victoria Rees (Drug Target Review)

A new nanoparticle-based vaccine has demonstrated success in ferret models of COVID-19, inducing strong neutralising antibodies against SARS-CoV-2.

The discovery and challenges of antibodies targeting GPCRs

26 February 2021 | By Domain Therapeutics

Watch our on-demand webinar which focused on the progress achieved in G protein-coupled receptor (GPCR) therapeutic antibody-based discovery and development.

ebook: Revolutionise your lab with a cutting-edge bioprocess platform to drive quality and efficiency

26 February 2021 | By IDBS

With the right solution organisations can simplify their lab-based working, while ensuring the highest level of compliance with regulatory requirements.

Resource library: Reagent resource for studying SARS-CoV-2 variants

23 February 2021 | By Sino Biological Inc.

Sino Biological has developed 80+ mutant proteins covering the newest mutations identified in SARS-CoV-2 variants, such as UK's B.1.1.7, Brazil's P.1.

Sino Biological Inc.

Experimental mAb subdues type 1 diabetes in laboratory mice

23 February 2021 | By Victoria Rees (Drug Target Review)

A monoclonal antibody given to mice reversed type 1 diabetes by suppressing the actions of glucagon, a study has shown.